Skip to content

Long-term Efficacy of Percutaneous Tibial Nerve Stimulation Applied to Patients With Faecal Incontinence.

Long-term Efficacy of Percutaneous Tibial Nerve Stimulation for Faecal Incontinence and New Approach for Partial Responders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05016453
Acronym
PTNSLONG
Enrollment
139
Registered
2021-08-23
Start date
2010-01-08
Completion date
2021-04-24
Last updated
2021-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal Incontinence

Keywords

percutaneous tibial nerve stimulation, anal physiology, faecal incontinence, partial response, long-term efficacy

Brief summary

Percutaneous tibial nerve stimulation (PTNS) is an ambulatory therapy validated for patients with Faecal Incontinence (FI) refractory to conservative treatment with proved short and mid-term efficacy. The investigators therefore aimed to evaluate the long-term efficacy of PTNS, considered 3 years of follow-up. The investigators also aimed to identify predictors of responses and suggest a new approach for partial responders.

Detailed description

Prospective single-centre cohort of patients with FI treated with PTNS was analysed. PTNS sessions were performed in three phases: weekly for three months in the first phase, biweekly for three months in the second phase, and monthly for six months in the third and final phase. Clinical control at the end of each phase and an additional follow-up was performed at 36 months. Wexner score, faecal urgency, bowel habits and quality of life for FI were assessed. Patients were categorized in three groups: optimal responders when there was an improvement in Wexner score \> 50%; partial responders if the improvement in Wexner score was 25-50%; and non-responders, when the improvement of Wexner score was \< 25%. Optimal responders and partial responders progressed into successive phases, whereas non-responders abandoned PTNS and other treatment options were offered.

Interventions

None listed

Sponsors

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of faecal incontinence for more than 6 months, refractory to conservative treatment.

Exclusion criteria

* Anatomic injuries that require surgery. * External anal sphincter lesion of \> 180º. * Unavailability to attend regularly outpatient clinic. * Major psychologic or psychiatric comorbidities

Design outcomes

Primary

MeasureTime frameDescription
Change in faecal incontinence assessed by Wexner ScoreBaseline compared to 3, 6, 12 and 36 months after start of PTNSRate of patients with improvement in faecal incontinence assessed by Wexner score (Maximum punctuation: 20 being severe incontinence. Minimum punctuation: 0, no incontinence).

Secondary

MeasureTime frameDescription
Predictors of good long-term improvement in Wexner scoreAt 3, 6 and 12 months after start of PTNSInfluence of previous obstetric or surgery history and duration of symptoms in the variation of Wexner score
Partial RespondersAt 3, 6 and12 months after start of PTNSIncidence of patients with a decrease in Wexner score between 25 and 50% compared to initial value, and their performance in the long term

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026